Dr. Vivitri Dewi Prasasty

Researcher
Universitas Atma Jaya, Indonesia


Highest Degree
Ph.D. in Life Sciences from University of Indonesia, Indonesia

Share this Profile

Area of Interest:

Biomedical Sciences
Drug Design
Protien Estimation
Therapeutics
Pharmaceutical Drugs

Selected Publications

  1. Siahaan, P., V.D. Prasasty, B.D. Simanjuntak, S. Hildayani and K. Anam, 2017. Structural stability of ADTC5 peptide: Conformational insights into dynamics and its binding mode. J. Trop. Life Sci., 7: 138-145.
    Direct Link  |  

  2. Prasasty, V.D., V. Winata and M. Hanafi, 2017. Identification and characterization of bacteral lipase from plateu soil in West Java. J. Kimia Terapan Indonesia, 18: 103-108.

  3. Hanafi, M., R. Rosmalena, V.D. Prasasty, L.Z. Udin and G. Primahana, 2017. In silico screening and designing synthesis of cinchona alkaloids derivatives as potential anticancer. J. Trop. Life Sci., 7: 121-127.
    Direct Link  |  

  4. Alaofi, A., E. Farokhi, V.D. Prasasty, A. Anbanandam, K. Kuczera and T.J. Siahaan, 2017. Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations. J. Biomol. Struct. Dyn., 35: 92-104.
    CrossRef  |  Direct Link  |  

  5. Satriyanto, A. and V.D. Prasasty, 2016. Role and progress of DHA dietary supply in brain development of maternal and golden periods. Int. J. Pharma Res. Health Sci., 4: 1268-1275.

  6. Nurbaya, S., Rosmalena and V.D. Prasasty, 2016. Inhibiting EGF receptor of colon cancer by bioactive compounds from Momordica charantia through molecular binding approach. Int. J. Pharma Res. Health Sci., 4: 1403-1406.

  7. Rosmalena, V.D. Prasasty, M. Hanafi, E. Budianto and B. Elya, 2015. Lignan derivatives potential as Plasmodium falciparum lactate dehydrogenase inhibitors: Molecular docking approach of antiplasmodial drug design. Int. J. Pharm. Pharm. Sci., 7: 394-398.

  8. Prasasty, V.D., M.E. Krause, U.S. Tambunan, A. Anbanandam, J.S. Laurence and T.J. Siahaan, 2015. 1H, 13C and 15N backbone assignment of the EC-1 domain of human E-cadherin. Biomolecular NMR Assignments, 9: 31-35.
    CrossRef  |  Direct Link  |  

  9. Prasasty, V. and A. Yulandi, 2015. Structure based design of novel rilpivirine analogues as HIV-1 non-nucleoside reverse transcriptase inhibitors through QSPR and molecular docking. Int. J. Pharm. Sci., 7: 340-345.

  10. Hanafi, M. and V.D. Prasasty, 2015. In silico screening of potential allicin compound from allium sativum as antiplasmodium. J. Kimia Terapan Indonesia, 17: 175-184.
    Direct Link  |  

  11. Prasasty, V.D., U.S.F. Tambunan and T.J. Siahaan, 2014. Homology modeling and molecular dynamics studies of EC1 domain of VE-cadherin to elucidate docking interaction with cadherin-derived peptide. OnLine J. Biol. Sci., 14: 155-162.
    Direct Link  |  

  12. Laksitorini, M., V.D. Prasasty, P.K. Kiptoo and T.J. Siahaan, 2014. Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers. Ther. Delivery, 5: 1143-1163.